艾司西酞普兰与帕罗西汀治疗惊恐障碍的随机对照研究(5)
[16]Baldwin DS, Huusom AKR, Maehlum E. Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study[J]. Br J Psychiatry, 2006, 189(3): 264-272.
[17]Kasper S, Loft H, Smith JR. Escitalopram is efficacious and well tolerated in the treatment of social anxiety disorder [J]. Int J Neuropsychopharmacol, 2002, 5:S131.
[18]Kasper S, Stein DJ, Loft H, et al. Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study[J]. Br J Psychiatry, 2005, 186: 222-226.
[19]Argyle N, Deltito J, Allerup P, et al. The Panic-Associated Symptom Scale: Measureing the severity of panic disorder[J]. Acta Psychiatr Scand, 1991, 83:20-26.
[20]汤毓华. 汉密顿抑郁量表[M].中国心理卫生杂志，1999，(增订版)：220-223.
[21]汤毓华. 汉密顿焦虑量表[M]. 中国心理卫生杂志，1999，(增订版)：253-255.
[22]吴文源. 临床疗效总评量表(CGI)[M].∥张明园. 精神科评定量表手册. 长沙，湖南科学技术出版社，1998：150-153.
[23]Sheehan KH, Sheehan DV. Assessing Treatment Effects in Clinical Trials with the Discan Metric of the Sheehan Disability Scale[J]. Int Clin Psychopharmacol, 2008, 23:70-83.
[24]郑筱萸.《药品临床试验管理规范》培训教材[M]. 北京:中国医药科技出版社，2000：125-126.
[25]蔡敏，沈鑫华. 艾司西酞普兰与帕罗西汀治疗惊恐障碍的比较[J]. 上海精神医学, 2008，20(1)：33-35.
[26]叶建飞，江红霞. 艾司西酞普兰与文拉法辛治疗抑郁症的对照研究[J]. 临床精神医学杂志, 2008，18(3)：155.
[27]张海音，张鸿燕，赵靖平，等. 帕罗西汀和氯丙咪嗪治疗惊恐障碍——随机双盲平行对照研究[J]. 中国心理卫生杂志，2000，14(6)：410-413.
[28]Ballenger JC, Davidson JR，Lecrubier Y, et al. Consensus Statement on Panic Disorder from the International Consensus Group on Depression and Anxiety[J]. J Clin Psychiatry, 1998, 59:47-54.
[29]Dhillon S, Scott LJ & Plosker GL. Escitalopram: A Review of its Use in the Management of Anxiety Disorders[J]. CNS Drugs, 2006, 20(9):763-790.
[30]Waugh J, Goa KL. Escitalopram: A Review of its Use in the Management of Major Depressive and Anxiety Disorders[J]. CNS Drugs, 2003 17(5):343-362.
责任编辑：胜利, http://www.100md.com(刘 琦 张鸿燕 蔡焯基 顾秀玲 栗克清 马 崔 张心保 李 )
[17]Kasper S, Loft H, Smith JR. Escitalopram is efficacious and well tolerated in the treatment of social anxiety disorder [J]. Int J Neuropsychopharmacol, 2002, 5:S131.
[18]Kasper S, Stein DJ, Loft H, et al. Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study[J]. Br J Psychiatry, 2005, 186: 222-226.
[19]Argyle N, Deltito J, Allerup P, et al. The Panic-Associated Symptom Scale: Measureing the severity of panic disorder[J]. Acta Psychiatr Scand, 1991, 83:20-26.
[20]汤毓华. 汉密顿抑郁量表[M].中国心理卫生杂志，1999，(增订版)：220-223.
[21]汤毓华. 汉密顿焦虑量表[M]. 中国心理卫生杂志，1999，(增订版)：253-255.
[22]吴文源. 临床疗效总评量表(CGI)[M].∥张明园. 精神科评定量表手册. 长沙，湖南科学技术出版社，1998：150-153.
[23]Sheehan KH, Sheehan DV. Assessing Treatment Effects in Clinical Trials with the Discan Metric of the Sheehan Disability Scale[J]. Int Clin Psychopharmacol, 2008, 23:70-83.
[24]郑筱萸.《药品临床试验管理规范》培训教材[M]. 北京:中国医药科技出版社，2000：125-126.
[25]蔡敏，沈鑫华. 艾司西酞普兰与帕罗西汀治疗惊恐障碍的比较[J]. 上海精神医学, 2008，20(1)：33-35.
[26]叶建飞，江红霞. 艾司西酞普兰与文拉法辛治疗抑郁症的对照研究[J]. 临床精神医学杂志, 2008，18(3)：155.
[27]张海音，张鸿燕，赵靖平，等. 帕罗西汀和氯丙咪嗪治疗惊恐障碍——随机双盲平行对照研究[J]. 中国心理卫生杂志，2000，14(6)：410-413.
[28]Ballenger JC, Davidson JR，Lecrubier Y, et al. Consensus Statement on Panic Disorder from the International Consensus Group on Depression and Anxiety[J]. J Clin Psychiatry, 1998, 59:47-54.
[29]Dhillon S, Scott LJ & Plosker GL. Escitalopram: A Review of its Use in the Management of Anxiety Disorders[J]. CNS Drugs, 2006, 20(9):763-790.
[30]Waugh J, Goa KL. Escitalopram: A Review of its Use in the Management of Major Depressive and Anxiety Disorders[J]. CNS Drugs, 2003 17(5):343-362.
责任编辑：胜利, http://www.100md.com(刘 琦 张鸿燕 蔡焯基 顾秀玲 栗克清 马 崔 张心保 李 )